SAVE MONEY ON TRAVEL DEALS

Northeastern University Professor Alexandros Makriyannis, Associate Professor Torjjorn Jarbe and former University of Connecticut researchers Chen Li and Qian Liu said their new molecule, AM1346, mimics, but is more powerful than, anandamide, an endogenous cannabinoid neurotransmitter found prominently in the brains of humans and animals. Anandamide is a naturally occurring part of the endocannabinoid system that regulates pain, controls heart rate and blood pressure, and modulates mood and appetite, the scientists said.

"AM1346 is a more potent and stable synthetic compound than anandamide", Makriyannis said. "It will serve as a test compound to study and understand more completely the endocannabinoid system and could have potential therapeutic implications as a topically applied pain killer."

The findings were published in a recent issue of the journal Psychopharmacology.

 BREAKING STORIES

Chemical linked to Parkinson's disease

MS progresses more rapidly in blacks

Online programs boost produce consumption

Family therapy helps suicidal teens

Differences between Crohn's and colitis

Carbon monoxide sickens 34 worshippers

Many older adults need pneumonia shot

Pathologist warns of herbal medicines

Bayer defends safety of contraceptives

Criteria not used to diagnose depression

Scientists convert proteins into prions

Scientists measure viral energy

Sugar switches involved in cell division

Kirchner to remain in ICU for 48 hours

FDA sees risks linked to the drug Tysabri

Anti-viral drug action is detailed

Moms' depression tied to teen behavior

Early abuse may affect physiology

Compromised family better than institution

Obama invites GOP to healthcare table